Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...

Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...

A Hudson Institute research project aiming to better understand and treat rare forms of ovarian cancer has received a big ...

Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology  Oslo, Norway, 8 December 2025 - Oncoinvent, a clinical stage, radiopharmaceutical ...

Seven scientists with the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium received another year of ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Germline pathogenic variants (gPVs) occur in a subset of patients with ovarian cancer, with the highest prevalence among those with Ashkenazi Jewish ancestry, followed by Asian and Hispanic patients, ...

Recent findings published in Scientific Reports highlight a promising target for ovarian cancer drug development, emphasizing ...

COIMBATORE: Under the National Health Mission (NHM), a group of surgical oncologists from eight medical college hospitals ...

Newswatch 16's Justin Gick spoke with a doctor about gynecological cancer and how early detection and access to care can save ...